CONMED to acquire Biorez for up to $250M

CONMED Corporation has announced a definitive agreement to acquire privately held Biorez, Inc. for $85 million at closing, plus up to $165 million in earnout payments. The transaction is expected to close in early August 2022.

“CONMED Corporation (NYSE: CNMD), a medical device company, has announced a definitive agreement to acquire privately held Biorez, Inc., a medical device start-up, on a cash-free, debt-free basis, for cash consideration of US$85 million at closing.”lw.com

• 2 sources
• lw.comLatham Watkins Represents Biorez Inc in Definitive Agreement to be Acquired by CONMEDAug 1, 2022
• conmed.gcs-web.comCONMED Announces Definitive Agreement to Acquire Biorez, Inc. | CONMEDAug 1, 2022

Summarized from public sources; check the original articles before acting on it.